Cargando…
Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia
BACKGROUND: Breast cancer is highly prevalent worldwide and leads to high health-care costs. HER2-positive subtype represents 30% of all breast cancers and is associated with a poor prognosis. Patients treated with anti-HER2 therapies frequently develop resistance and require pharmacological treatme...
Autores principales: | Sánchez-Calderón, Diana, Pedraza, Adriana, Mancera Urrego, Catalina, Mejía-Mejía, Aurelio, Montealegre-Páez, Ana Lorena, Perdomo, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025648/ https://www.ncbi.nlm.nih.gov/pubmed/32104023 http://dx.doi.org/10.2147/CEOR.S220726 |
Ejemplares similares
-
Factors related to healthcare costs of road traffic accidents in Bucaramanga, Colombia
por: Rivera-Carvajal, Raquel, et al.
Publicado: (2022) -
AR‐V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost‐Saving Analysis
por: Pacheco‐Orozco, Rafael Adrián, et al.
Publicado: (2020) -
Evaluation of Liquid Biopsy in Patients with HER2-Positive Breast Cancer
por: Huai, Jianguo, et al.
Publicado: (2021) -
Communities on the move: community participation in health in rural territories of Buenaventura District in Colombia
por: Blandón-Lotero, Laura Catalina, et al.
Publicado: (2020) -
We Are Very Similar but Not Really: The Moderating Role of Cultural Identification for Refugee Resettlement of Venezuelans in Colombia
por: Ayala, Yarid, et al.
Publicado: (2020)